Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.92 | 3.91% | 0.03 |
VRCA closed down 0.29 percent on Wednesday, November 20, 2024, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 1,2,3 Retracement Bearish | Bearish Swing Setup | 3.91% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.91% | |
| NR7 | Range Contraction | 3.91% | |
| Narrow Range Bar | Range Contraction | 3.91% | |
| Wide Bands | Range Expansion | 3.91% | |
| Oversold Stochastic | Weakness | 3.91% | |
| MACD Bullish Signal Line Cross | Bullish | 3.61% | |
| Outside Day | Range Expansion | 3.61% | |
| Wide Bands | Range Expansion | 3.61% | |
| Oversold Stochastic | Weakness | 3.61% |
| Alert | Time |
|---|---|
| 10 DMA Support | about 2 hours ago |
| Rose Above Previous Day's High | about 2 hours ago |
| 2x Volume Pace | about 2 hours ago |
| 1.5x Volume Pace | about 2 hours ago |
| Down 3% | about 2 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Medication Pharmaceutical Products Clinical Trial Skin Diseases Treatment Of Skin Diseases Common Warts
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.4 |
| 52 Week Low | 0.7043 |
| Average Volume | 847,443 |
| 200-Day Moving Average | 5.05 |
| 50-Day Moving Average | 1.39 |
| 20-Day Moving Average | 1.12 |
| 10-Day Moving Average | 0.86 |
| Average True Range | 0.14 |
| RSI (14) | 37.11 |
| ADX | 31.9 |
| +DI | 16.60 |
| -DI | 29.97 |
| Chandelier Exit (Long, 3 ATRs) | 1.31 |
| Chandelier Exit (Short, 3 ATRs) | 1.13 |
| Upper Bollinger Bands | 1.80 |
| Lower Bollinger Band | 0.44 |
| Percent B (%b) | 0.33 |
| BandWidth | 121.92 |
| MACD Line | -0.20 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.0098 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.99 | ||||
| Resistance 3 (R3) | 0.99 | 0.96 | 0.98 | ||
| Resistance 2 (R2) | 0.96 | 0.93 | 0.96 | 0.97 | |
| Resistance 1 (R1) | 0.92 | 0.91 | 0.90 | 0.92 | 0.96 |
| Pivot Point | 0.89 | 0.89 | 0.88 | 0.89 | 0.89 |
| Support 1 (S1) | 0.85 | 0.86 | 0.83 | 0.85 | 0.81 |
| Support 2 (S2) | 0.82 | 0.84 | 0.82 | 0.81 | |
| Support 3 (S3) | 0.78 | 0.82 | 0.80 | ||
| Support 4 (S4) | 0.78 |
